15 April 2026
15 April 2026
CrossBridge Bio develops a dual-payload ADC technology created by Kyoji Tsuchikama at the University of Texas Health Science Center.
The pharma giant’s CEO, Joaquin Duato, forecasts strong growth acceleration for 2026, driven in part by psoriasis pill, Icotyde.
Funding will enable progress on the ADCE-T02 Phase I Tiffany-01 cohort expansion in a range of solid tumours.
An analyst noted that this uptick may be a case of “frontloading”, meaning the EU’s 2026 export growth outlook may not be as strong.
As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community's attention turns to Amsterdam.
This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per GlobalData.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
